TCRT
TCRT
NASDAQ · Biotechnology

Alaunos Therapeutics Inc

$2.37
+0.29 (+13.94%)
Financial Highlights (FY 2026)
Revenue
6.7K
Net Income
-5,536,227
Gross Margin
Profit Margin
-83,520.0%
Rev Growth
-88.0%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 33.9% 33.9%
Operating Margin -84,500.0% -76,050.7% -6.9% -6.6%
Profit Margin -83,520.0% -79,344.0% -6.2% -6.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 6.7K 56.1K 1.35M 1.27M
Gross Profit 457.7K 431.9K
Operating Income -5,674,175 -42,698,641 -93,195 -83,844
Net Income -5,536,227 -41,660,571 -84,207 -82,182
Gross Margin 33.9% 33.9%
Operating Margin -84,500.0% -76,050.7% -6.9% -6.6%
Profit Margin -83,520.0% -79,344.0% -6.2% -6.5%
Rev Growth -88.0% -88.0% +20.4% +2.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 2.88M 2.33M
Total Equity 1.84M 1.81M
D/E Ratio 1.56 1.28
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -5,592,021 -44,418,227 -111,401 -119,566
Free Cash Flow -113,905 -126,135